DSC 512 Pill - yellow round, 10mm
Generic Name: quizartinib
Pill with imprint DSC 512 is Yellow, Round and has been identified as Vanflyta 26.5 mg. It is supplied by Daiichi Sankyo Inc.
Vanflyta is used in the treatment of Acute Myeloid Leukemia and belongs to the drug class multikinase inhibitors. Vanflyta 26.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for DSC 512
Vanflyta
- Generic Name
- quizartinib
- Imprint
- DSC 512
- Strength
- 26.5 mg
- Color
- Yellow
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Daiichi Sankyo Inc.
- National Drug Code (NDC)
- 65597-0511
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Idarubicin
Idarubicin is used for acute myeloid leukemia, leukemia, leukocytoclastic vasculitis, solid tumors
Daunorubicin
Daunorubicin is used for acute lymphocytic leukemia, acute myeloid leukemia, acute nonlymphocytic ...
Midostaurin
Midostaurin is used for acute myeloid leukemia, systemic mastocytosis
Azacitidine
Azacitidine is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic myelogenous ...
More about Vanflyta (quizartinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.